Literature DB >> 962328

Somatic generation of antibody diversity.

G Matthyssens, N Hozumi, S Tonegawa.   

Abstract

Hybridization of lambda-mRNAs to excess liver DNA yielded results compatible with gene reiteration frequencies of three or less. Purified mRNA from tumors producing structurally different lambda chains were used in competition hybridization experiments. An unlabeled lambda-mRNA competed with another, labelled mRNA to the same extent as homologous unlabelled lambda-mRNA. Mouse DNA was digested with Eco R-I restriction endonuclease and fractionated by gel electrophoresis. A DNA fragment carrying the V lambda-gene(s) was indentified in this digest. This fragment hybridized with lambda-mRNAs coding for two different lambdaV regions equally well. These results indicate that base sequence homology among lambda-mRNAs is so high that any lambda-mRNA should cross-hybridize with all or most of germ line V lambda genes. From amino acid sequence data, it is argued that there are probably more than 25 different lambdaV regions. Hence it is concluded that the number of germ line genes is too small to account for the diversity of lambda chains.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 962328

Source DB:  PubMed          Journal:  Ann Immunol (Paris)        ISSN: 0300-4910


  3 in total

1.  Cloning of an immunoglobulin variable region gene from mouse embryo.

Authors:  S Tonegawa; C Brack; N Hozumi; R Schuller
Journal:  Proc Natl Acad Sci U S A       Date:  1977-08       Impact factor: 11.205

2.  Development of a Prognostic Nomogram for Acute Myeloid Leukemia on IGHD Gene Family.

Authors:  Qunxiang Qiu; Ping Zhang; Nan Zhang; Yan Shen; Shifeng Lou; Jianchuan Deng
Journal:  Int J Gen Med       Date:  2021-08-10

3.  An antibody-based biomarker discovery method by mass spectrometry sequencing of complementarity determining regions.

Authors:  Lennard J M Dekker; Lona Zeneyedpour; Eric Brouwer; Martijn M van Duijn; Peter A E Sillevis Smitt; Theo M Luider
Journal:  Anal Bioanal Chem       Date:  2010-11-24       Impact factor: 4.142

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.